Design, Synthesis and Anti‐Proliferative Assessment of 4‐Aminoquinoline‐ and 4‐Aminoquinoline‐Benzoxaborole Conjugates
- 16 November 2026
- journal article
- Published by Wiley in ChemMedChem
- Vol. 21 (22)
Abstract
A series of 4‐aminoquinoline analogues and 4‐aminoquinoline‐benzoxaborole conjugates were synthesized and evaluated for their antiproliferative activities against two distinct breast cancer cell lines: MCF‐7 (estrogen receptor‐positive, ER+) and MDA‐MB‐231 (triple‐negative). Preliminary dose‐response assays revealed compound 5e , a 4‐aminoquinoline–benzoxaborole conjugate, as the most active compound against MCF‐7 cells. Structure–activity relationship (SAR) analysis indicated that the cytotoxic potency of the series increased with the length of the alkyl spacer connecting the pharmacophoric moieties. To assess selectivity, HEK‐293 cells were employed as a non‐cancerous control line, and most compounds exhibited minimal cytotoxicity, except compound 5d , which showed moderate effects. To gain preliminary structural insights, exploratory molecular docking studies were performed against the ligand‐binding domain of estrogen receptor alpha (ERα). This integrated experimental‐computational approach highlights the identification of promising preliminary hits. Overall, the findings show that 4‐aminoquinoline–benzoxaborole conjugates exhibit antiproliferative activity against breast cancer cells, with greater potency towards MCF‐7 cells.Funding Information
- Anusandhan National Research Foundation (YSS/2015/000879/CS)
This publication has 36 references indexed in Scilit:
- Design, synthesis, and biological evaluation of novel 4-aminoquinoline derivatives as potent membrane-targeting antifungal agentsBioorganic & Medicinal Chemistry Letters, 2025
- Isatin-indoloquinoxaline click adducts with a potential to overcome platinum-based drug-resistance in ovarian cancerBioorganic Chemistry, 2023
- Evaluation of the biological activity of different 4-aminoquinolines for the development of new drugs against painful and inflammatory disordersEuropean Journal of Medicinal Chemistry Reports, 2023
- Challenges Based on Antiplasmodial and Antiviral Activities of 7‐Chloro‐4‐aminoquinoline DerivativesChemMedChem, 2023
- SAR studies of quinoline and derivatives as potential treatments for Alzheimer’s diseaseArabian Journal of Chemistry, 2023
- Functionalized 3-hydroxy-3-aminoquinoline-oxindole hybrids as promising dual-function anti-plasmodialsEuropean Journal of Medicinal Chemistry Reports, 2022
- A comprehensive review on the biological interest of quinoline and its derivativesBioorganic & Medicinal Chemistry, 2021
- Development of a bioavailable boron-containing PI-103 Bioisostere, PI-103BEBioorganic & Medicinal Chemistry Letters, 2020
- Dictamnine promotes apoptosis and inhibits epithelial-mesenchymal transition, migration, invasion and proliferation by downregulating the HIF-1α and Slug signaling pathwaysChemico-Biological Interactions, 2018
- Chalcone–benzoxaborole hybrids as novel anticancer agentsBioorganic & Medicinal Chemistry Letters, 2016